VC firm · US · frazierls.com

Frazier Life Sciences

Last cheque observed Jul 2026; 3 cheques observed across the 16 sources we track.

deployingwebsite livecoverage medium

What they say, and what they did

They say

Type
VC firm
Cheque size
not stated
Stages
not stated
Cold pitches
not stated

From their own site: “Frazier Life Sciences is a longstanding biotech investment firm with venture and public strategies partnering with and building companies developing novel therapeutics.”

We observed

Rounds they appear in
3 (3 led)
Median round size
$130M not their cheque
Sole named investor
never
Last seen
Jul 2026

An announcement gives the size of the round, not the size of this investor's cheque. The only rounds that imply a cheque are those where they were the sole named investor.

The record

CompanyStageRoleRoundWhen
Series Bled$130MJul 2026
Sidewinder TherapeuticsUS · Ventureburn
Series Bled$137MApr 2026
Aspen NeuroscienceUS · Ventureburn
Series Cled$115MNov 2025

Every row links the article it came from · 3 appearances recorded

Something wrong here? Tell us — corrections are free and need no account.